MG
TMDX icon

Mather Group’s Transmedics TMDX Stock Holding History

Mather Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13K Hold
17
– – ﹤0.01% 1789
2026
Q1 		$1.69K Buy
+17
New +$2.22K ﹤0.01% 1719
2025
Q1 		– Sell
-16
Closed -$998 – 1860
2024
Q4 		$998 Hold
16
– – ﹤0.01% 1614
2024
Q3 		$2.51K Buy
+16
New +$2.46K ﹤0.01% 1432

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Mather Group's TMDX Position: Q2 2026 in Review

Mather Group held its Transmedics (TMDX) position steady in Q2 2026 at 17 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #1789.

Mather Group first reported a position in TMDX in Q3 2024 and has held it in 4 quarters since. The position peaked at $2.51K in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Mather Group held 17 shares of Transmedics worth $1.13K as of Q2 2026.
  • Mather Group left its Transmedics share count unchanged in Q2 2026.
  • Transmedics made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1789 holding.
  • Mather Group first reported a position in Transmedics in Q3 2024 and has held it in 4 quarters since.
  • Mather Group's Transmedics position peaked at $2.51K in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.